🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Pharma Diagnostics & Analytics

Benchmark revenue and EBITDA valuation multiples for public comps like Oxford Nanopore Techs, Adaptive Biotech, Genomictree, Biohit and Bio-Techne.

Pharma Diagnostics & Analytics

See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company EV EV/LTM Revenue EV/LTM EBITDA
$10.2B n/a n/a
$8.6B 7.1x 20.5x
$1.7B 8.5x -27.3x
$1.5B 5.7x -10.7x
$919M n/a n/a
$186M 10.1x 13.2x
$185M 2465.0x -5.4x
$174M n/a n/a
$46.3M 2.7x 13.8x
$33.2M 13.2x -8.2x
$20.0M 15.3x -9.0x
$19.7M n/a n/a
$6.3M n/a n/a
-$6.0M n/a 0.1x
-$22.4M -0.8x n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.